BORN2GROW supports biotech start-up Venneos with its further growth
27-Sep-2017 -
Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells.
“We are thrilled to have BORN2GROW ...
cell analysis
financing
High-Tech Gründerfonds Management
+4